Cooper Pharma corporate presentation by Ayman CHEIKH LAHLOU, CEO, for mHealth...Levi Shapiro
Ayman CHEIKH LAHLOU, CEO, Cooper Pharma, presents Apirl 21, 2021, to the mHealth Israel community. Cooper at a Glance: History, DNA & Key Figures. Commitments Towards Quality. Partnerships in Licensing. Cooper Pharma’s vision is to be a leading player in the Healthcare and Pharmaceutical sector
at local and regional levels, through a large range of products and services. Make medicines more available to patients by:
Producing and marketing branded generic and innovate drugs of the highest quality at the best price. Making all drugs available at any time and everywhere in Morocco. Manufacturing of over 200 specialties in nearly 300 presentations both for its own range of branded generics and on behalf of international pharmaceutical companies. Cooper Pharma focuses part of its strategy on the international market,
thus considering exports as a vector of development and
competitiveness. Through its wholesale activity with 9 distribution companies across
Morocco, Cooper Pharma can provide its citizens with all imported & manufactured drugs with a reduced lead times to pharmacies. Therapeutic areas include GASTROENTEROLOGY, GENERAL MEDICINE &
ANTIBIOTHERAPY, WOMEN’S HEALTH, SELF MEDICATION, CLINICS, HOSPITALS & ONCOLOGY, SPECIALTY. THERE IS STILL ROOM FOR IMPROVEMENT TO UPGRADE
PATIENT & PHYSICIAN EXPERIENCES IN MOROCCO
Further progress could be made. We need to make it happen in short & middle term with long-term realistic targets by leveraging experience from others.
Cooper Pharma corporate presentation by Ayman CHEIKH LAHLOU, CEO, for mHealth...Levi Shapiro
Ayman CHEIKH LAHLOU, CEO, Cooper Pharma, presents Apirl 21, 2021, to the mHealth Israel community. Cooper at a Glance: History, DNA & Key Figures. Commitments Towards Quality. Partnerships in Licensing. Cooper Pharma’s vision is to be a leading player in the Healthcare and Pharmaceutical sector
at local and regional levels, through a large range of products and services. Make medicines more available to patients by:
Producing and marketing branded generic and innovate drugs of the highest quality at the best price. Making all drugs available at any time and everywhere in Morocco. Manufacturing of over 200 specialties in nearly 300 presentations both for its own range of branded generics and on behalf of international pharmaceutical companies. Cooper Pharma focuses part of its strategy on the international market,
thus considering exports as a vector of development and
competitiveness. Through its wholesale activity with 9 distribution companies across
Morocco, Cooper Pharma can provide its citizens with all imported & manufactured drugs with a reduced lead times to pharmacies. Therapeutic areas include GASTROENTEROLOGY, GENERAL MEDICINE &
ANTIBIOTHERAPY, WOMEN’S HEALTH, SELF MEDICATION, CLINICS, HOSPITALS & ONCOLOGY, SPECIALTY. THERE IS STILL ROOM FOR IMPROVEMENT TO UPGRADE
PATIENT & PHYSICIAN EXPERIENCES IN MOROCCO
Further progress could be made. We need to make it happen in short & middle term with long-term realistic targets by leveraging experience from others.
MARK IV is a content provider for medical and scientific animation. It is backed by over four decades of professional expertise in the field of medicine. It is located in Coimbatore, South India with offices in UK and Singapore.
www.markivstudios.com
MARK IV is a content provider for medical and scientific animation. It is backed by over four decades of professional expertise in the field of medicine. It is located in Coimbatore, South India with offices in UK and Singapore
A Trust-Centric Healthcare Journey | Full Presentation of PharmaLedger's 1st ...PharmaLedger
In this #1 Open Webinar | A trust-centric healthcare journey presentation, you will find:
An introduction to the PharmaLedger project presented by Lynn Wang (Johnson & Johnson)
Topic 1 | Clinical Supply Traceability presented by Francesco Spoto (Novartis) and Chad Sklodosky (Pfizer)
Topic 2 | Finished Goods Traceability presented by Dr Jan Wortmann (Bayer) and Bernhard Salb (Roche)
Topic 3 | ePI – Electronic Product Information presented by Patrick Maher (Novartis) and Ken Thursby (MSD)
Topic 4 | Anti-Counterfeiting presented by Daniel Fritz (Novartis) and Alberto Lòpez (Imprensa Nacional Casa da Moeda)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
PharmaLedger Press Release #2 June 2020 PharmaLedger
PharmaLedgers June 2020 press release covers the strong foundations in the project’s first year and how it set the stage for accelerated development and ecosystem engagement.
The press release also announces the establishment of PharmaLedger’s Advisory Board and the outlook for 2021.
—
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today!
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Have a look at our agenda: http://bit.ly/_IDMP_Agenda
MARK IV is a content provider for medical and scientific animation. It is backed by over four decades of professional expertise in the field of medicine. It is located in Coimbatore, South India with offices in UK and Singapore.
www.markivstudios.com
MARK IV is a content provider for medical and scientific animation. It is backed by over four decades of professional expertise in the field of medicine. It is located in Coimbatore, South India with offices in UK and Singapore
A Trust-Centric Healthcare Journey | Full Presentation of PharmaLedger's 1st ...PharmaLedger
In this #1 Open Webinar | A trust-centric healthcare journey presentation, you will find:
An introduction to the PharmaLedger project presented by Lynn Wang (Johnson & Johnson)
Topic 1 | Clinical Supply Traceability presented by Francesco Spoto (Novartis) and Chad Sklodosky (Pfizer)
Topic 2 | Finished Goods Traceability presented by Dr Jan Wortmann (Bayer) and Bernhard Salb (Roche)
Topic 3 | ePI – Electronic Product Information presented by Patrick Maher (Novartis) and Ken Thursby (MSD)
Topic 4 | Anti-Counterfeiting presented by Daniel Fritz (Novartis) and Alberto Lòpez (Imprensa Nacional Casa da Moeda)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
PharmaLedger Press Release #2 June 2020 PharmaLedger
PharmaLedgers June 2020 press release covers the strong foundations in the project’s first year and how it set the stage for accelerated development and ecosystem engagement.
The press release also announces the establishment of PharmaLedger’s Advisory Board and the outlook for 2021.
—
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today!
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Have a look at our agenda: http://bit.ly/_IDMP_Agenda
Meet GE Healthcare, Pfizer, Novartis Pharma, Boehringer-Ingelheim Pharma and ...Torben Haagh
The leading European conference on the topic of IDMP Implementation - Impact on Data, Systems and Processes is due to take place in Berlin from 24 – 25 June 2015. Don't miss your chance to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
There are now limited places available, so make sure you secure your conference ticket today! Learn more here:
http://bit.ly/_Agenda-
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
EuroBioMed, France:
Private-public collaborations to boost open innovation
Dr Franck Molina
President of EDCA, Chair of diagnosis group of Eurobiomed
Director of Sysdiag
=======================================
http://www.eurobioforum.eu
160317 presentatie memo patch® innovation in medication adherence (bram van ...SMBBV
Presentation by Bram van Dijck, CEO TheraSolve on MemoPatch, an innovation in medication adherence. Presented during Science Meets Business meeting from SMB Life Sciences during Health Valley Event 2016.
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR PartnershipCESAR
Learn more about the Brazilian project that won silver medal in the 2014 iGEM synthetic biology in Boston / USA. A partnership between C.E.S.A.R and LIKA-UFPE.
This presentation by Morris Kleiner (University of Minnesota), was made during the discussion “Competition and Regulation in Professions and Occupations” held at the Working Party No. 2 on Competition and Regulation on 10 June 2024. More papers and presentations on the topic can be found out at oe.cd/crps.
This presentation was uploaded with the author’s consent.
Acorn Recovery: Restore IT infra within minutesIP ServerOne
Introducing Acorn Recovery as a Service, a simple, fast, and secure managed disaster recovery (DRaaS) by IP ServerOne. A DR solution that helps restore your IT infra within minutes.
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Orkestra
UIIN Conference, Madrid, 27-29 May 2024
James Wilson, Orkestra and Deusto Business School
Emily Wise, Lund University
Madeline Smith, The Glasgow School of Art
This presentation, created by Syed Faiz ul Hassan, explores the profound influence of media on public perception and behavior. It delves into the evolution of media from oral traditions to modern digital and social media platforms. Key topics include the role of media in information propagation, socialization, crisis awareness, globalization, and education. The presentation also examines media influence through agenda setting, propaganda, and manipulative techniques used by advertisers and marketers. Furthermore, it highlights the impact of surveillance enabled by media technologies on personal behavior and preferences. Through this comprehensive overview, the presentation aims to shed light on how media shapes collective consciousness and public opinion.
Have you ever wondered how search works while visiting an e-commerce site, internal website, or searching through other types of online resources? Look no further than this informative session on the ways that taxonomies help end-users navigate the internet! Hear from taxonomists and other information professionals who have first-hand experience creating and working with taxonomies that aid in navigation, search, and discovery across a range of disciplines.
0x01 - Newton's Third Law: Static vs. Dynamic AbusersOWASP Beja
f you offer a service on the web, odds are that someone will abuse it. Be it an API, a SaaS, a PaaS, or even a static website, someone somewhere will try to figure out a way to use it to their own needs. In this talk we'll compare measures that are effective against static attackers and how to battle a dynamic attacker who adapts to your counter-measures.
About the Speaker
===============
Diogo Sousa, Engineering Manager @ Canonical
An opinionated individual with an interest in cryptography and its intersection with secure software development.
Getting started with Amazon Bedrock Studio and Control Tower
20140402_MARKET PLACE_CATALOGUE_Health
1. MARKET PLACE
¡Encuentra tus socios!
Envíanos las referencias que te interesen y te ponemos en contacto: seimed@redit.es
La Enterprise Europe Network (EEN) es una red apoyada por la Comisión Europea y a la que pertenecen cerca de 600 entidades agrupadas en regiones.
Está presente en más de 50 países y proporciona servicios gratuitos a las pymes para mejorar su competitividad mediante la innovación, internacionalización y cooperación tecnológica y empresarial.
SEIMED es la sub-red de la EEN que proporciona estos servicios a las empresas de la Comunidad Valenciana y Región de Murcia.
Si quieres que publiquemos tu perfil tecnológico en nuestra base de datos, para que sea accesible a todas las entidades de la EEN y así sus empresas clientes puedan interesarse en colaborar contigo, dínoslo y te indicaremos el procedimiento.
Más información en: www.enterprise-europe-network.ec.europa.eu / www.seimed.eu
2. COGNITIVE BEHAVIOURAL THERAPY SMARTPHONE APPLICATION FOR PSYCHOLOGICAL DISORDERS
12 GB 42O1 3RBI
Treatment for anxiety, depression, panic disorders and work stress in accordance with the National Institute for Health and Clinical Excellence (NICE) guidelines TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: SME PARTNER SOUGHT: Large organizations from across Europe who wish
to license the application for the benefit of their employees
PLATFORM OF ANTIMICROBIAL TECHNOLOGY
13 GB 46P4 3S7R
Cutting-edge drug discovery expertise has been applied to identify and validate naturally derived antibacterial and antifungal active molecules TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: SCOTTISH, CLINICAL STAGE BIOTECHNOLOGY COMPANY PARTNER SOUGHT: Consumer health care/cosmeceutical company partners for licensing opportunities to integrate this novel technology in to current or new/pipeline products
SERVICE INTEGRATORS OPERATING IN PRIVATE/PUBLIC HEALTH CARE, PSYCHIATRY AND MEDICAL TOURISM SOUGHT
13 FI 30h9 3SNY
Innovative outpatient cloud service which structures patient care using multi-modal communication between the care team, patient and the caregiver. The tool is a global SaaS TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: FINLAND ORGANIZATION: COMPANY PARTNER SOUGHT: Service integrators operating in the health care sector
TRIAGE AND DECISION SUPPORT SYSTEM FOR HOSPITAL EMERGENCY CARE
13 SE 67CL 3RW1
Management system to shorten waiting times for the initial medical assessment. The web-based system has been developed and tested in major hospitals in Sweden TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: SWEDEN ORGANIZATION: SME in the e-health sector PARTNER SOUGHT: Partners interested in adaption/development of the system to local language and administrative approach
SYNTHETIC TUBULYSINS AS SUPER-POTENT DRUGS FOR TARGETED AND CONVENTIONAL CANCER CHEMOTHERAPY
13 IT 55Y2 3RVZ
The novel derivatives show improved cytotoxic profile relative to both natural tubulysins and conventional chemotherapic agents TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: ITALY ORGANIZATION: SME PARTNER SOUGHT: From private or public sector, interested in co-developing applications for chemotherapy
PATENTED MULTIFUNCTIONAL MASSAGE STONE
13 DE 0855 3SJX
Ergonomic stamp shape that allows fatigue-proof work for several hours. The material can be heated to a comfortable (not too hot) temperature. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: GERMANY ORGANIZATION: SMALL COMPANY PARTNER SOUGHT: Commercial or licensing partnership, technical support, marketing and production
3. SELF ACTIVATING MULTIFUNCTIONAL SYSTEMS FOR CHRONIC WOUND HEALING
13 GB 403U 3SNS
Advanced therapeutic dressing (drug loaded) that takes an active part in the wound healing process providing a faster, cost effective and potential complete healing of chronic ulcerated wounds TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: UNIVERSITY PARTNER SOUGHT: Pharmaceutical or biotechnology industry partners i) to undertake in-vivo testing using suitable animal wound models and ii) for product prototyping for clinical trials
IMPLEMENTATION OF A WEARABLE (PORTABLE) SYSTEM
12 RO 662C 3RIU
System for aiding people with special needs (elderly, children, etc) in the daily traffic routine through cities TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: ROMANIA ORGANIZATION: TECHNICAL UNIVERSITY PARTNER SOUGHT: Innovative SMEs and R&D performers in the field of ICT in EU/International R&D Programs
BIOFEEDBACK DEVICE FOR CORRECT BODY POSTURE
13 BG 0528 3RLD
It provides signal (light, voice or vibration) when spine curving is detected and can be used in kinesitherapy (physiotherapy), fitness centers, in schools and by office workers TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: BULGARIA ORGANIZATION: RESEARCHER PARTNER SOUGHT: License, technical and/or manufacturing agreement or joint venture
NON-INVASIVE PRENATAL DIAGNOSIS OF DOWN'S SYNDROME AND OTHER ANEUPLOIDIES
13 GB 4103 3SDJ
Single, simple, spot urine metabolomics test that could rapidly penetrate the multi-million dollar global women’s health market TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: COMPANY PARTNER SOUGHT: medical companies and research organisations
MECHANICAL MEDICAL DEVICE, COUPLED WITH A COGNITIVE BEHAVIOURAL THERAPY, THAT RELIEVES CHRONIC PAIN
13 FR 32I9 3S4P
It reproduces the hand’s ability to put pressure on all soft muscular tissues, thus getting immediate relief, it goes with a Cognitive Behavioral Therapy helping relieve chronic pain TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: FRANCE ORGANIZATION: HEALTH PROFESSIONAL PARTNER SOUGHT: Commercial and technical cooperations to produce the device and market it in Europe
IMPROVING OF THE FETAL MONITORING TECHNIQUE
12 RO 662C 3RIY
Improving of the biosignal processing and analysis methods for the fetal electrocardiogram (fECG), fetal phonocardiogram (fPCG) and fetal photoplethysmogram (fPPG) and to the investigation of data fusion in fetal monitoring. TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY & ORGANIZATION: Technical University from ROMANIA PARTNER SOUGHT: Innovative SMEs and R&D performers in the field of ICT in EU/International R&D Programs
4. ENCAPSULATION OF FLAVONOIDS IN MULTIPLE EMULSIONS
13 GB 42O1 3SNW
Rutin and anthocyanin flavonoids have beneficial effects to human health such as antioxidant and anti-inflammatory. They can be encapsulated with a new system using a spinning disc reactor (SDR) as a novel processing aid. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: UNIVERSITY PARTNER SOUGHT: Food processing and pharmaceutical company
AGENT FOR OPTIMIZING FERTILIZATION MEDIA (IN VITRO FERTILIZATION)
13 DE 0855 3SC4
Technology using a liver derived plasma protein as essential agent for in vitro fertilization. Blood-free agent and fertilization success increased. Applicable for women with infertility or not becoming pregnant due to illness or treatment. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: GERMANY ORGANIZATION: UNIVERSITY PARTNER SOUGHT: Industrial partners are sought for licensing and further development
DEVICE THAT EASES THE REDUCTION PROCEDURE OF WRIST FRACTURES
13 SE 67CM 3RM0
It reduces the cost of treatment and minimizes the risk for complications and further surgery. Working prototype available. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: SWEDEN ORGANIZATION: Medical Doctor from a University hospital PARTNER SOUGHT: Looking for commercial partners in the Medtech industry for license agreements in order to bring the invention to the market
3D PAIN MONITORING SYSTEM
12 GB 44O6 3RER
Reduction of the cost of caring for patients suffering significant pain whilst improvement of overall quality of life. Non- verbal identifying location and type of pain, helping with a better pacing of medication intake and replacing currently used 2D methods. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: London University PARTNER SOUGHT: Healthcare organisations to license the product
RADIATION SENSOR – MONITORING AND DISPLAYING DATA IN REAL TIME DURING RADIOTHERAPY TREATMENTS
12 GB 44O6 3RE2
Data is stored for later processing. A web interface integrates with existing health systems. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: London based SME PARTNER SOUGHT: To work on miniaturization of prototype hardware design, software/hardware integration, electronic component integration and power consumption management
FORCE SENSING FLOOR TO MEASURE PEOPLE’S BALANCE AND MOVEMENT PERFORMANCE
13 GB 42O1 3RWD
Aimed to improve balance and encourage movement through games or for review by clinical professionals TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: UNITED KINGDOM ORGANIZATION: UNIVERSITY PARTNER SOUGHT: Research centre and or companies to investigate different applications domains and discuss possible commercial cooperation with technical assistance
5. PRODUCTION OF CROSS-LINKED GELATIN PARTICLES FOR PHARMACEUTICAL APPLICATIONS
13 NL 60AH 3ROB
Technology platform for the synthesis of high quality cross-linked gelatin particles. Foreseen applications are hemostat agent, tissue repair, wound healing or cell attachment scaffold TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: THE NETHERLANDS ORGANIZATION: SME PARTNER SOUGHT: pharmaceutical, life science or biotech partners
SPECIAL PILLOW FOR PREVENTION AND TREATMENT OF VENOUS THROMBOSIS
13 PL 61AL 3RL7
Indispensable part of any trip especially by plane. Its use prevents deep vein thrombosis, pulmonary embolism, eliminates the swelling of the feet around the ankles and stimulates the flow of venous blood in the extremities due to starting the pump-calf muscle TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: POLAND ORGANIZATION: ENTERPRISE PARTNER SOUGHT: Partners from medical industry under license agreement
ROBOTIZED ORTHOTIC SUIT
12 RO 662C 3RK8
Project objective: achievement of a robotized orthotic suit / exoskeleton, which allows the assisted person to accomplish an orthostatism and gait in the same conditions as the physiological conditions. TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: ROMANIA ORGANIZATION: Technical University PARTNER SOUGHT: Innovative SMEs and R&D performers in the field of Robotics and Mechatronics in EU/International R&D Programs
SYSTEMS BIOLOGY APPROACH TO CANCER DIAGNOSIS AND TREATMENT
12 DE 1697 3QKI
Drug & patient stratification via virtual clinical trials for personalised medicine approaches to cancer diagnosis TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: GERMANY ORGANIZATION: COMPANY PARTNER SOUGHT: Clinical or pharmaceutical industry partners
PHASE III MULTI-CENTRIC CLINICAL STUDY IN EUROPE (CELL THERAPY – GASTRO-ENTEROLOGY)
12 FR 38m5 3QX2
Study for the repair of deficient external anal muscle (sphincter) in patients suffering from faecal incontinence TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: FRANCE ORGANIZATION: BIOTECHNOLOGY COMPANY PARTNER SOUGHT: Clinical sites, clinical investigators, surgeons, Key Opinion Leaders in the pathology of faecal incontinence for a technical cooperation
DEVICE FOR PRINTING TEXTS, NUMBERS AND VISUAL SIGNS IN BRAILLE WRITING SYSTEM
12 LV 58AD 3R97
The desired technology must be ready for immediate implementation. TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: LATVIA ORGANIZATION: SME PARTNER SOUGHT: Commercial agreement with technical assistance
6. BEE VENOM BASED COSMETIC PRODUCTS 13 GB 403U 3S5N
Product beneficial to treat a number of skin conditions including pre-cancerous blemishes, psoriasis and also for wrinkle reduction TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: UNITED KINGDOM ORGANIZATION: SME PARTNER SOUGHT: Cosmetics industry and research institutes with innovative solutions to co-develop, test/help certify and commercialize such products
DECISION SUPPORT SYSTEM FOR MELANOMA DIAGNOSIS
10 ES 23D2 3I35
Software support system for helping dermatologists in the diagnosis of the melanoma, that uses images obtained with dermatoscopic techniques and also photographs of the patients. It can be used as an automated way to decide the urgency. TYPE OF PROFILE: TECHNOLOGY OFFER COUNTRY: SPAIN ORGANIZATION: RESEARCH GROUP PARTNER SOUGHT: Any kind of collaboration
PS: HORIZON 2020 - DEVICE FOR FOSTERING AND CONTROLING CORRECT OR DESIRED POSTURE
RDHR20131011001 TYPE OF PROFILE: PARTNER SEARCH COUNTRY: CROATIA ORGANIZATION: Innovator PARTNER SOUGHT: Partners should be from robotic industry, high technology sector and/or health sector and should have knowledge for improving product's technology and providing market placement
INDUSTRIAL PARTNERS FOR THE DEVELOPMENT OF A LEAD VACCINE AGAINST PREGNANCY-ASSOCIATED MALARIA
TRFR20131121001
Invention patented opening the way of a Vaccine development against Pregnancy-associated Malaria. Looking for industrial partners to join the technology development with industrial standards of a such vaccine production and a CRO company to lead preclinical studies. TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: FRANCE ORGANIZATION: A National Research Center PARTNER SOUGHT: Industrial partners
MEDICAL TEXTILE IMPLANT
TRCH20130711001
Textile structure, with very discrete dimensions and suitable to support the fixation of a tendon in ligament reconstruction surgery. It should meet biocompatibility requirements. To be fixed to a metal structure (preferably titanium). Materials approved in the major medical device markets (Europe, US, Japan). TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: SWITZERLAND ORGANIZATION: COMPANY
License agreement or technical co-operation is sought.
A NOVEL MARKER FOR ENDOMETRIUM
TRUK20130726002
A UK University seeks a binding agent, such as an antibody, aptamer or similar molecule that binds strongly to a surface marker of endometrium, but not to adjacent tissues, allowing accurate in vitro and in vivo identification of endometrium. The marker will provide the basis for the development of novel diagnostic assays. TYPE OF PROFILE: TECHNOLOGY REQUEST COUNTRY: UK ORGANIZATION: University PARTNER SOUGHT: A partner in industry or academia is sought for a license, technical co-operation and joint venture, financial resources.